VFA
RDY icon

Virtus Fund Advisers’s Dr. Reddy's Laboratories RDY Stock Holding History

Virtus Fund Advisers’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-115,860
Closed -$1.7M – 131
2024
Q1 		$1.7M Buy
+115,860
New +$1.69M 6.01% 6

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtus Fund Advisers's RDY Position: Q2 2024 in Review

Virtus Fund Advisers sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 115,860 shares — an estimated $1.7M sold.

Virtus Fund Advisers first reported a position in RDY in Q1 2024 and held it in 1 quarter. The position peaked at $1.7M in Q1 2024. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • Virtus Fund Advisers reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
  • Virtus Fund Advisers sold 115,860 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $1.7M.
  • Virtus Fund Advisers first reported a position in Dr. Reddy's Laboratories in Q1 2024 and held it in 1 quarter.
  • Virtus Fund Advisers's Dr. Reddy's Laboratories position peaked at $1.7M in Q1 2024.
  • 222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Virtus Fund Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.